Showing 241-250 of 328 grants

Title Institution Researcher Program Duration Total Award Amount
Study of ALDH3B2 as a regulator of pancreatic beta cell neogenesis Joslin Diabetes Center Inc. Jian Li Cures 01-August-2023 to 31-July-2026 $212,708.89
Effectiveness and safety of sotagliflozin in slowing kidney function decline in persons with type 1 diabetes and moderate to severe diabetic kidney disease: The SUGARNSALT Trial Joslin Diabetes Center Inc. Alessandro Doria Improving Lives 01-January-2024 to 31-December-2028 $8,913,450.00
Towards FDA approval of Autonomous AI for diabetic retinopathy screening in youth Johns Hopkins University Risa Wolf Improving Lives 01-January-2023 to 31-December-2025 $637,547.20
REGULATORY ROLE OF CADM1 DURING AUTOIMMUNE DIABETES Johns Hopkins University Matthew Poy Cures 01-December-2024 to 30-November-2027 $900,000.00
A Novel Bifunctional Biologic for Type 1 Diabetes Johns Hopkins University Giorgio Raimondi Cures 01-February-2025 to 31-January-2028 $995,376.00
Curing New-Onset Type 1 Diabetes with a Restorative Antibody Therapy Johns Hopkins University Dax Fu Cures 01-April-2025 to 31-March-2026 $200,000.00
Assessing immunotherapeutic potential of a natural IgM antibody for the treatment of T1D Johns Hopkins University Abdel Hamad Cures 01-June-2024 to 31-January-2026 $199,881.88
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema Jaeb Center for Health Research Adam Glassman Improving Lives 01-September-2022 to 01-January-2026 $273,424.00
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-January-2026 $750,000.00